Body Protection Compound 157, PL 14736. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
What we suggest instead. Pick one route and stay on it. For topical use, follow the serum steps below — the whole vial goes into one 30 mL bottle and nothing is injected. For subcutaneous use, reconstitute with bacteriostatic water instead and work from the dose table; the calculator on this page is set up for that route.
Paid affiliate link.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 1 mg | daily | 0.03 mL | 3 u | 14 | 14 mg |
| Weeks 3–4 | 2 mg | daily | 0.06 mL | 6 u | 14 | 28 mg |
| Week 5 onward per 4 weeks from here on |
3 mg | daily | 0.09 mL | 9 u | 28 | 84 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Topical formulation | 0.05–0.1% concentration | daily, topical | Set by body weight — can't be turned into a single amount to draw | ||
| Low reported (SC) | 1 mg | 1× daily | 0.03 mL | 3 u | 100 doses |
| Standard (SC) | 2 mg | 1× daily | 0.06 mL | 6 u | 50 doses |
| Upper reported (SC) | 3 mg | 1× daily | 0.09 mL | 9 u | 33 doses |
A copper-binding tripeptide, related to GHK-Cu but with a different amino acid sequence. Most of the published work is cosmetic and in-vitro, focused on hair follicle and dermal papilla models rather than systemic administration. Human data is limited to small cosmetic studies.
Buy AHK-CuPaid affiliate links.
Adding 3 mL of bacteriostatic water to a 100 mg vial gives 33.3 mg/mL. That is the mix the subcutaneous figures on this page are worked out from. The topical serum route uses 1 mL of sterile distilled water instead — see the steps above. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for AHK-Cu cover a 0.05–0.1% topical formulation, and 1–3 mg subcutaneously, mirroring the closely related GHK-Cu. This site lists each figure with the source it came from rather than giving a single recommended number.
At 33.3 mg/mL, a 1 mg dose is 3 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 100 doses.
AHK-Cu is graded limited. The figures are sparse — a single programme or community-reported numbers. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Need this on one page to print, screenshot or send?
Make a dose card →Side-by-side with the compounds it is most often weighed against — doses, evidence tier and how each is mixed.
Compounds in the same class, or browse the full catalogue.
The C-terminal tripeptide of α-melanocyte-stimulating hormone, studied for anti-inflammatory activity in colitis and dermatitis mo…
A synthetic fragment of thymosin beta-4, the actin-sequestering protein. Full-length Tβ4 reached human trials for dry eye and card…
Every compound compared in one table: dose range, how often, half-life and evidence tier.